Cutaneous and systemic manifestations of mastocytosis

American Family Physician

Volumn 59, Issue 11, 1999, Pages

  Alto, William A ^a   Clarcq, Lisa ^a  

^a Maine Dartmouth Family Practice Residency   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CHLORPHENIRAMINE; CROMOGLYCATE DISODIUM; DOXEPIN; HISTAMINE H1 RECEPTOR ANTAGONIST; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYZINE;

CELL MEMBRANE; CLINICAL FEATURE; MAST CELL; MASTOCYTOSIS; PUVA; REVIEW; SKIN BIOPSY; SUDDEN DEATH; SYSTEMIC MASTOCYTOSIS; URTICARIA PIGMENTOSA;

BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LABORATORY TECHNIQUES AND PROCEDURES; MASTOCYTOSIS; MIDDLE AGED; PATIENT EDUCATION; TEACHING MATERIALS; URTICARIA PIGMENTOSA;

EID: 0344655614     PISSN: 0002838X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (21)

1. Metcalfe DD. Classification and diagnosis of mastocytosis: current status. J Invest Dermatol 1991;96: 2S-4S.
2. Longley J, Duffy TP, Kohn S. The mast cell and mast cell disease. J Am Acad Dermatol 1995;32:545-61 [Published erratum in J Am Acad Dermatol 1995; 33:523].
3. Kamajian G, Felix J. Acute mastocytosis: a potential dermatologic emergency. J Am Osteopath Assoc 1993;93:792-6.
4. Young WF Jr, Maddox DE. Spells: in search of a cause. Mayo Clin Proc 1995;70:757-65.
5. Horan RF, Austen KF. Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital. J Invest Dermatol 1991;96:5S-14S.
6. Galli SJ. New concepts about the mast cell. N Engl J Med 1993;328:257-65.
7. Gruchalla RS. Southwestern Internal Medicine Conference: mastocytosis: developments during the past decade. Am J Med Sci 1995;309:328-38.
8. Leaf FA, Jaecks EP, Rodriguez DR. Bullous urticaria pigmentosa. Cutis 1996;58:358-60.
9. Kettelhut BV, Metcalfe DD. Pediatric mastocytosis. Ann Allergy 1994;73:197-202.
10. Azana JM, Torrelo A, Mediero IG, Zambrano A. Urticaria pigmentosa: a review of 67 pediatric cases. Pediatr Dermatol 1994;11:102-6.
11. Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises, case 7-1992. A 57-year-old man with a 20-year history of episodic headache, flushing, hypotension and occasional syncope. N Engl J Med 1992;326:472-81.
12. Tharp MD. Mast cell disease and its diagnosis [Editorial]. J Invest Dermatol 1995;104:885-6.
13. Schwartz LB, Metcalfe DD, Miller JS, Earl H, Sullivan T. Tryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis. N Engl J Med 1987;316:1622-6.
14. Roberts U 2d, Sweetman BJ, Lewis RA, Austen KF, Oates JA. Increased production of prostaglandin D2 in patients with systemic mastocytosis. N Engl J Med 1980;303:1400-4.
15. Roberts U 2d, Oates JA. Biochemical diagnosis of systemic mast cell disorders. J Invest Dermatol 1991;96:19S-25S.
16. Golkar L, Bernhard JD. Mastocytosis. Lancet 1997;349:1379-85.
17. Miner PB Jr. The role of the mast cell in clinical gastrointestinal disease with special reference to systemic mastocytosis. J Invest Dermatol 1991;96:40S-44S.
18. Frieri M, Alling DW, Metcalfe DD. Comparison of the therapeutic efficacy of cromolyn sodium with that of combined chlorpheniramine and cimetidine in systemic mastocytosis: results of a double-blind clinical trial. Am J Med 1985;78:9-14.
19. Metcalfe DD. The treatment of mastocytosis: an overview. J Invest Dermatol 1991;96:55S-59S.
20. Austen KT. Systemic mastocytosis [Editorial]. N Engl J Med 1992;326:639-40.
21. Butterfield JH, Kao PC, Klee GG, Yocum MW. Aspirin idiosyncrasy in systemic mast cell disease: a new look at mediator release during aspirin desensitization. Mayo Clin Proc 1995;70:481-7.